Ex vivo lentiviral gene therapy for mucopolysaccharidosis type IVA

被引：0
|
作者：
Celik, Betul [1 ]
Rintz, Estera [2 ]
Nidhi, Fnu [3 ]
Khan, Shaukat [4 ]
Tomatsu, Shunji [4 ]
机构：
[1] Univ Delaware, Wilmington, DE USA
[2] Univ Gdansk, Gdansk, Poland
[3] Univ Delaware, Newark, DE USA
[4] Neumors Childrens Hosp, Wilmington, DE USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2024年 / 141卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2023.107789
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
50
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector
    Di Domenico, C
    Villani, GRD
    Di Napoli, D
    Reyero, EGY
    Lombardo, A
    Naldini, L
    Di Natale, P
    HUMAN GENE THERAPY, 2005, 16 (01) : 81 - 90
  • [32] Substrate degradation enzyme therapy (SDET) for mucopolysaccharidosis type IVA
    Tomatsu, Shunji
    Sawamoto, Kazuki
    Sakai, Tokiko
    Kitazawa, Ikue
    Futatsumori, Hideyuki
    Nakamura, Takehiko
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S140 - S140
  • [33] Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated Ex Vivo Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIA
    Ellison, Stuart M.
    Liao, Aiyin
    Wood, Shaun
    Taylor, Jessica
    Youshani, Amir Saam
    Rowlston, Sam
    Parker, Helen
    Armant, Myriam
    Biffi, Alessandra
    Chang, Lucas
    Farzaneh, Farzin
    Wynn, Rob
    Jones, Simon A.
    Heal, Paul
    Gaspar, H. Bobby
    Bigger, Brian W.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 13 : 399 - 413
  • [34] Pre-Clinical Development of an Ex-Vivo Lentiviral-Based Hematopoietic Stem/ Progenitor Cells (HSPC)-Gene Therapy (GT) for Mucopolysaccharidosis Type IVA (MPSIVA) as Part of an Innovative GT Platform Approach for LSDs with Skeletal Involvement
    Crippa, Stefania
    Berti, Margherita
    Santi, Ludovica
    De Ponti, Giada
    Hernandez, Raisa
    Quaranta, Pamela
    Cossutta, Matilde
    Zonari, Erika
    Ceriotti, Selene
    Visigalli, Ilaria
    Basso-Ricci, Luca
    Albertini, Paola
    Sanvito, Francesca
    Paoli, Antonella
    Volpi, Nicola
    Morrone, Amelia
    Radrizzani, Marina
    Parini, Rossella
    Scala, Serena
    Aiuti, Alessandro
    Bernardo, Maria Ester
    MOLECULAR THERAPY, 2024, 32 (04) : 730 - 730
  • [35] Skeletal Damage and Cross-correction after ex-vivo Gene Therapy in Mucopolysaccharidosis type I Hurler
    Santi, Ludovica
    Crippa, Stefania
    Capo, Valentina
    Penna, Sara
    Savoia, Evelyn
    De Ponti, Giada
    Alberti, Gaia
    Berti, Margherita
    Ceriotti, Selene
    Consiglieri, Giulia
    Tucci, Francesca
    Riminucci, Mara
    Corsi, Alessandro
    Barbero, Andrea
    Martin, Ivan
    Sanvito, Francesca
    Norata, Rossana
    Rocchi, Martina
    Bolamperti, Simona
    Villa, Isabella
    Aiuti, Alessandro
    Villa, Anna
    Bernardo, Maria Ester
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 30 - 31
  • [36] BIOCHEMICAL ENGRAFTMENT AND CLINICAL OUTCOMES OF EX-VIVO AUTOLOGOUS STEM CELL GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE IIIA
    Guha, Anthea
    Wynn, Robert
    Bigger, Brian
    Kinsella, Jane
    Holley, Rebecca
    Potter, Jane
    Ellison, Stuart
    Thrasher, Adrian
    Booth, Kathryn
    Buckland, Karen
    Izotova, Natalia
    Rust, Stewart
    Weisberg, Daniel
    Church, Heather
    Tylee, Karen
    Brammeier, Kathryn
    Jones, Simon
    Lee, Helena
    Ford, Laura
    Sadegholnejat, Atusa
    Jones, Ceri
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 62 - 63
  • [37] Lentiviral mediated stem cell gene therapy corrects a mouse model of mucopolysaccharidosis type IIIA
    Bigger, Brian
    Langford-Smith, Alex
    Wilkinson, Fiona
    Langford-Smith, Kia
    Sergijenko, Ana
    Wraith, Ed
    Wynn, Rob
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (02) : S8 - S8
  • [38] Lentiviral vector-mediated stem cell gene therapy for mucopolysaccharidosis type IIIA (MPSIIIA)
    Langford-Smith, Alex
    Wilkinson, Fiona
    Bennett, William
    Hopwood, John
    Wraith, Ed
    Wynn, Rob
    Bigger, Brian
    HUMAN GENE THERAPY, 2009, 20 (11) : 1396 - 1397
  • [39] PROMISING RESULTS WITH EX VIVO LENTIVIRAL HSPC GENE THERAPY IN ADA-SCID
    不详
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2021, 185 (08) : 2291 - 2292
  • [40] Brain-targeted ex vivo lentiviral gene therapy: Implications for MPS and beyond
    Bradbury, Allison M.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2023, 31
12345